Condition
Unresectable Lung Non-Small Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Unresectable Lung Non-Small Cell Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), China (1)). By phase: Phase 1 (2), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Unresectable Lung Non-Small Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Understand cancer cachexia subtypes in advanced cancers | — | Pleasanton, California | Recruiting | Aug 20, 2026 |
| Observational study on cancer cachexia subtypes | — | Fort Smith, Arkansas and 224 other locations | Recruiting | Oct 10, 2023 |
| Evaluating Serplulimab with Chemotherapy for Lung Cancer Treatment | Phase 2 | Hangzhou, Zhejiang | Recruiting | May 1, 2023 |
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
| Using papaverine with chemoradiation to treat advanced non-small cell lung cancer | Phase 1 | Duarte, California and 1 other locations | Recruiting | Nov 29, 2021 |
| Personalized vaccine treatment for advanced melanoma, breast cancer, and lung cancer | Phase 1 | Seattle, Washington | Recruiting | Oct 28, 2021 |
All recruiting trials (6)
-
Understand cancer cachexia subtypes in advanced cancers
This study tests how cancer cachexia presents in people with advanced colorectal, pancreatic, or lung cancer to see if different subtypes relate to outcomes.
-
Observational study on cancer cachexia subtypes
This study is trying to identify different types of weight and muscle loss in patients with advanced colorectal, lung, or pancreatic cancers to help improve future treatments.
-
Evaluating Serplulimab with Chemotherapy for Lung Cancer Treatment
This study is testing if adding Serplulimab to chemotherapy can help people with advanced lung cancer turn their tumors into ones that can be surgically removed and live longer without the cancer coming back.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Using papaverine with chemoradiation to treat advanced non-small cell lung cancer
This study is testing the best dose of papaverine combined with chemotherapy and radiation to see if it helps people with advanced non-small cell lung cancer live longer and control their tumors better.
-
Personalized vaccine treatment for advanced melanoma, breast cancer, and lung cancer
This study is testing a personalized vaccine combined with a treatment called nivolumab to see if it can help people with advanced melanoma, breast cancer, or lung cancer fight their tumors better.
Related topics
Quick answers
How many Unresectable Lung Non-Small Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.